(Q38070137)

PubMed publication ID

28 August 2017

1 reference

title

Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

Stefan Ambs

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

Sharon A Glynn

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

8

Giorgio Trinchieri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

author name string

Lisa A Ridnour

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

Christopher H Switzer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

Julie L Heinecke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

Howard A Young

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

David A Wink

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

27 December 2012

1 reference

PubMed publication ID

23271799

28 August 2017

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

page(s)

1340-1346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

Increased apoptosis in infiltrating mononuclear cells of colorectal cancer: a mechanism for tumor escape

13 May 2020

cites work

1 reference

12 December 2020

Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion

1 reference

12 December 2020

Toll-like receptors and their ligands.

1 reference

12 December 2020

Topical imiquimod in the treatment of metastatic melanoma to skin

1 reference

12 December 2020

Toll-like Receptors and Their Signaling Mechanisms

1 reference

12 December 2020

PGE2-mediated upregulation of iNOS in murine breast cancer cells through the activation of EP4 receptors.

1 reference

12 December 2020

Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity.

1 reference

12 December 2020

Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide.

1 reference

12 December 2020

Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.

1 reference

12 December 2020

Toll-like receptor control of the adaptive immune responses

1 reference

12 December 2020

The role of early expression of inducible nitric oxide synthase in human breast cancer

1 reference

12 December 2020

Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod

1 reference

12 December 2020

Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88

1 reference

12 December 2020

Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases.

1 reference

12 December 2020

Toll-like receptors on tumor cells facilitate evasion of immune surveillance

1 reference

12 December 2020

The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine

1 reference

12 December 2020

Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice

1 reference

12 December 2020

The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas

1 reference

12 December 2020

Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

1 reference

12 December 2020

Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils

1 reference

12 December 2020

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection

1 reference

12 December 2020

TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance

1 reference

12 December 2020

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

1 reference

12 December 2020

Early experience with novel immunomodulators for cancer treatment

1 reference

12 December 2020

Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4.

1 reference

12 December 2020

Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors

1 reference

12 December 2020

Toll-like receptor 9 (TLR9) agonists in the treatment of cancer

1 reference

12 December 2020

An exploratory study of systemic administration of the toll-like receptor-7 agonist 852A in patients with refractory metastatic melanoma

1 reference

12 December 2020

Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA

1 reference

12 December 2020

Role of neutrophils in BCG immunotherapy for bladder cancer

1 reference

12 December 2020

Anti-tumor effect of DNA-based vaccination and dSLIM immunomodulatory molecules in mice with Ph+ acute lymphoblastic leukaemia

1 reference

12 December 2020

Cancer-related inflammation

1 reference

12 December 2020

The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy

1 reference

12 December 2020

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

1 reference

12 December 2020

Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer

1 reference

12 December 2020

How location governs toll-like receptor signaling

1 reference

12 December 2020

The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

1 reference

12 December 2020

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment

1 reference

12 December 2020

Toll-like receptor signaling in cell proliferation and survival

1 reference

12 December 2020

Cyclooxygenase 2 modulates killing of cytotoxic T lymphocytes by colon cancer cells

1 reference

12 December 2020

Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy

1 reference

12 December 2020

High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer

1 reference

12 December 2020

Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade.

1 reference

12 December 2020

Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling.

1 reference

12 December 2020

Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma

1 reference

12 December 2020

Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression

1 reference

12 December 2020

Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation

1 reference

12 December 2020

Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patients

1 reference

12 December 2020

COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer

1 reference

12 December 2020

Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis

1 reference

12 December 2020

TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer

1 reference

12 December 2020

Toll-like receptor modulators: a patent review (2006-2010).

1 reference

12 December 2020

Toll-like receptors in inflammation of the central nervous system

1 reference

12 December 2020

Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma.

1 reference

12 December 2020

Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma

1 reference

12 December 2020

Toll-like receptors and diabetes: a therapeutic perspective

1 reference

12 December 2020

Myeloid suppressor cells and immune modulation in lung cancer

1 reference

12 December 2020

Adaptors in toll-like receptor signaling and their potential as therapeutic targets

1 reference

12 December 2020

Anticancer TLR agonists on the ropes

1 reference

12 December 2020

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

1 reference

12 December 2020

S-nitrosylation of EGFR and Src activates an oncogenic signaling network in human basal-like breast cancer

1 reference

12 December 2020

Roles of toll-like receptors in cancer: a double-edged sword for defense and offense

1 reference

12 December 2020

Nitric oxide synthase and breast cancer: role of TIMP-1 in NO-mediated Akt activation

1 reference

12 December 2020

Monthly intravesical bacillus Calmette-Guérin maintenance therapy for non-muscle-invasive bladder cancer: 10-year experience in a single institute

1 reference

12 December 2020

Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma

1 reference

12 December 2020

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

12 December 2020

10.1158/1078-0432.CCR-12-0408

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json

13 May 2020

PubMed publication ID

23271799

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6314173&resulttype=core&format=json